Nicotine improves delayed recognition in schizophrenic patients

Psychopharmacology

Volumn 174, Issue 3, 2004, Pages 334-340

  Myers, Carol S ^a   Robles, Olalla ^a   Kakoyannis, A Nancy ^a   Sherr, Jay D ^a   Avila, Matthew T ^a   Blaxton, Teresa A ^a   Thaker, Gunvant K ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Delayed recognition; Nicotine; Schizophrenia; Working memory

Indexed keywords

NICOTINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPTH PERCEPTION; DRUG EFFECT; FACE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MEMORY DISORDER; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; RECOGNITION; SCHIZOPHRENIA; SMOKING; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE;

EID: 3843123190     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1764-8     Document Type: Article

References (49)

1. Adler LE, Hoffer LJ, Griffith J, Waldo MC, Freedman R (1992) Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenia. Biol Psychiatry 32:607-616
2. Adler LE, Hoffer LD, Wiser A, Freedman R (1993) Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150:1856-1861
3. Adler LE, Olincy A, Harris JG, Griffith J, Stevens K, Flach K, Nagamoto H, Bickford P, Leonard S, Freedman R (1998) Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 24:189-202
4. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn. American Psychiatric Association, Arlington, Va.
5. Avila MT, Sherr JD, Hong E, Myers CS, Thaker GK (2003) Effects of nicotine on leading saccades during smooth pursuit eye movements in smokers and nonsmokers with schizophrenia. Neuropsychopharmacology 28:2184-2191
6. Brioni JD, Arneric SP (1993) Nicotinic receptor agonists facilitate retention of avoidance training: participation of dopaminergic mechanisms. Behav Neural Biol 59:57-62
7. Buccafusco JJ, Jackson WJ (1991) Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys. Neurobiol Aging 12:233-238
8. Cabeza R, Nyberg L (2000) Imaging cognition II: an empirical review of 275 PET and fMRI studies. J Cognit Neurosci 12:1-47
9. Chini B, Raimond E, Elgoyhen AB, Moralli D, Balzaretti M, Heinemann S (1994) Molecular cloning and chromosomal localization of the human 7-nicotinic receptor subunit gene (CHRNA7). Genomics 19:379-381
10. Coon H, Plaetke R, Holik J, Hoff M, Myles-Worsley M, Waldo M, Freedman R, Byerley W (1993) Use of a neuropsychological trait in linkage analysis of schizophrenia. Biol Psychiatry 34:277-289
11. Dalack GW, Healy DJ, Meador-Woodruff JH (1998) Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry 155:1490-1501
12. Dunne MP, MacDonald D, Hartley LR (1986) The effects of nicotine upon memory and problem solving performance. Physiol Behavior 37:849-854
13. Elrod K, Buccafusco JJ, Jackson WJ (1988) Nicotine enhances delayed matching-to-sample performance by primates. Life Sci 43:277-287
14. Freedman R, Adler LE, Bickford P, Byerley W, Coon H, Cullum CM, Griffith JM, Harris JG, Leonard S, Miller C, Myles-Worsley M, Nagamoto HT, Rose G, Waldo M (1994) Schizophrenia and nicotinic receptors. Harvard Rev Psychiatry 2:179-192
15. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, Polymeropoulos M, Holik J, Hopkins J, Hoff M, Rosenthal J, Waldo MC, Reimherr F, Wender P, Yaw J, Young DA, Breese CR, Adams C, Patterson D, Adler LE, Kruglyak L, Leonard S, Byerley W (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 94:587-592
16. George TP, Vessicchio JC, Termine A, Sahady DM, Head CA, Pepper WT, Kosten TR, Wexler BE (2002) Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology 26:75-85
17. Haxby JV, Ungerleider LG, Horwitz B, Rapoport SI, Grady CL (1995) Hemispheric differences in neural systems for face working memory: a PET-rCBF study. Hum Brain Map 3:68-82
18. Heatherton TF, Kozlowski LT, Fagerström K-O (1991) The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 86:1119-1127
19. Heishman SJ, Taylor RC, Henningfield JE (1994) Nicotine and smoking: a review of effects on human performance. Exp Clin Psychopharmacol 2:345-395
20. Hindmarch I, Sherwood N (1995) Nicotine and cognitive effects. In: Clarke PBS, Quik M, Thurau K (eds) Advances in pharmacological sciences: effects of nicotine on biological systems, II. Birkhauser Verlag, Basel, pp 189-194
21. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA (1986) Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 143:993-997
22. Joseph MH, Peters SL, Gray JA (1993) Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure. Psychopharmacology 110:187-192
23. Kelly C, McCreadie RG (1999) Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry 156:1751-1757
24. Klein C, Andresen B (1991) On the influence of smoking upon smooth pursuit eye movements of schizophrenics and normal controls. J Psychophysiol 5:361-369
25. Ksir C (1992) Behavioral neuropharmacology of nicotine. In: Watson RR (ed) Drugs of abuse and neurobiology. CRC Press, Boca Raton, Fla., pp 131-148
26. Leonard S, Adams C, Breese CR, Adler LE, Bickford P, Byerley W, Coon H, Griffith JM, Miller C, Myles-Worsley M, Nagamoto H, Rollins Y, Stevens KE, Waldo M, Freedman R (1996) Nicotinic receptor function in schizophrenia. Schizophr Bull 22:431-445
27. Levin ED (1992) Nicotinic systems and cognitive function. Psychopharmacology 108:417-431
28. Levin ED, Rezvani AH (2000) Development of nicotinic drug therapy for cognitive disorders. Eur J Pharmacol 393:141-146
29. Levin ED, Simon BB (1998) Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 138:217-230
30. Levin ED, Castonguay M, Ellison GD (1987) Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats. Behav Neural Biol 48:206-212
31. Levin ED, Wilson W, Rose JE, McEvoy J (1996) Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15:429-436
32. McKay AP, McKenna PJ, Bentham P, Mortimer AM, Holbery A, Hodges JR (1996) Semantic memory is impaired in schizophrenia. Biol Psychiatry 39:929-937
33. Newhouse PA, Kelton M (2000) Nicotinic systems in central nervous systems disease: degenerative disorders and beyond. Pharm Acta Helv 74:91-101
34. Olincy A, Young DA, Freedman R (1997) Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol Psychiatry 42:1-5
35. Olincy A, Ross RG, Young DA, Roath M, Freedman R (1998) Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology 18:175-185
36. Park S, Knopick C, McGurk S, Meltzer HY (2000) Nicotine impairs spatial working memory while leaving spatial attention intact. Neuropsychopharmacology 22:200-209
37. Parks RW, Becker RE, Rippey RF, Gilbert DG, Matthews JR, Kabatay E, Young CS, Vohs C, Danz V, Keim P, Collins GT, Zigler SS, Urycki PG (1996) Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study. Neuropsychol Rev 6:61-79
38. Peters R, McGee R (1982) Cigarette smoking and state-dependent memory. Psychopharmacology 76:232-235
39. Rusted JM, Graupner L, Warburton DM (1995) Effects of post-trial administration of nicotine on human memory: evaluating the conditions for improving memory. Psychopharmacology 119:405-413
40. Saykin AJ, Gur RC, Gur RE, Mozley PD, Mozley LH, Resnick SM, Kester B, Stafiniak P (1991) Neuropsychological function in schizophrenia: Selective impairment in memory and learning. Arch Gen Psychiatry 48:618-624
41. Sherr JD, Myers CS, Avila M, Blaxton TA, Thaker GK (2002) The effects of nicotine on specific eye tracking measures in schizophrenia. Biol Psychiatry 52:721-728
42. Smith RC, Singh A, Infante M, Khandat A, Kloos A (2002) Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology 27:479-497
43. Socci DJ, Sanberg PR, Arendash GW (1995) Nicotine enhances Morris water maze performance of young and aged rats. Neurobiol Aging 16:857-860
44. Spitzer RL, Endicott JE (1995) The structured clinical interview for DSM-IV. American Psychiatric Press, Washington D.C.
45. Stassen HH, Bridler R, Hagele S, Mehmann B, Schinzel A, Weisbrod M, Scharfetter C (2000) Schizophrenia and smoking: evidence for a common neurobiological basis? Am J Med Genet 96:173-177
46. Terry AVJ, Buccafusco JJ, Jackson WJ (1993) Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys. Pharmacol Biochem Behav 45:925-929
47. Waldo MC, Adler LE, Leonard S, Olincy A, Ross RG, Harris JG, Freedman R (2000) Familial transmission of risk factors in the first-degree relatives of schizophrenic people. Biol Psychiatry 47:231-239
48. White HK, Levin ED (1999) Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology 143:158-165
49. Zarrindast MR, Sadegh M, Shafaghi B (1996) Effects of nicotine on memory retrieval in mice. Eur J Pharmacol 295:1-6